Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.070
+0.060 (1.99%)
Jun 12, 2026, 3:04 PM CST
SHE:300026 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 9,223 | 10,575 | 11,386 | 12,738 | 17,064 | 23,523 | |
Market Cap Growth | -16.35% | -7.12% | -10.61% | -25.35% | -27.46% | 70.96% |
Enterprise Value | 8,322 | 9,968 | 11,349 | 13,109 | 18,344 | 24,054 |
Last Close Price | 3.07 | 3.52 | 3.76 | 4.17 | 5.56 | 7.61 |
PE Ratio | 246.43 | 571.75 | 530.38 | 25.14 | 27.34 | 34.22 |
Forward PE | - | 16.83 | 16.83 | 16.83 | 16.83 | 16.83 |
PS Ratio | 1.97 | 2.14 | 1.97 | 2.09 | 2.57 | 3.07 |
PB Ratio | 1.06 | 1.22 | 1.29 | 1.44 | 2.02 | 2.96 |
P/TBV Ratio | 1.20 | 1.39 | 1.48 | 1.66 | 2.36 | 3.49 |
P/FCF Ratio | 13.48 | 15.53 | 17.27 | 10.77 | - | - |
P/OCF Ratio | 11.55 | 13.03 | 13.36 | 8.32 | 22.89 | 60.07 |
PEG Ratio | - | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 |
EV/Sales Ratio | 1.78 | 2.02 | 1.96 | 2.15 | 2.76 | 3.14 |
EV/EBITDA Ratio | 16.66 | 22.11 | 28.47 | 16.23 | 18.83 | 19.77 |
EV/EBIT Ratio | 45.39 | 56.06 | 110.81 | 25.43 | 25.32 | 24.00 |
EV/FCF Ratio | 12.16 | 14.64 | 17.22 | 11.08 | - | - |
Debt / Equity Ratio | 0.06 | 0.06 | 0.10 | 0.17 | 0.25 | 0.25 |
Debt / EBITDA Ratio | 1.03 | 1.06 | 1.90 | 1.78 | 2.03 | 1.55 |
Debt / FCF Ratio | 0.75 | 0.78 | 1.29 | 1.30 | - | - |
Net Debt / Equity Ratio | -0.12 | -0.11 | -0.05 | 0.00 | 0.11 | 0.08 |
Net Debt / EBITDA Ratio | -2.31 | -2.15 | -1.14 | -0.05 | 0.91 | 0.53 |
Net Debt / FCF Ratio | -1.52 | -1.43 | -0.69 | -0.03 | -35.48 | -2.27 |
Asset Turnover | 0.44 | 0.46 | 0.50 | 0.50 | 0.55 | 0.70 |
Inventory Turnover | 1.31 | 1.41 | 1.51 | 1.35 | 1.61 | 2.40 |
Quick Ratio | 3.42 | 3.21 | 2.57 | 2.89 | 1.79 | 2.46 |
Current Ratio | 4.70 | 4.46 | 3.79 | 4.29 | 2.76 | 3.31 |
Return on Equity (ROE) | 0.33% | 0.26% | 0.26% | 5.79% | 7.57% | 8.74% |
Return on Assets (ROA) | 1.07% | 1.03% | 0.56% | 2.63% | 3.73% | 5.75% |
Return on Invested Capital (ROIC) | 0.77% | 0.60% | 0.51% | 4.69% | 7.00% | 9.83% |
Return on Capital Employed (ROCE) | 2.00% | 2.00% | 1.10% | 5.00% | 7.30% | 10.50% |
Earnings Yield | 0.26% | 0.18% | 0.19% | 3.98% | 3.66% | 2.92% |
FCF Yield | 7.42% | 6.44% | 5.79% | 9.29% | -0.15% | -1.21% |
Dividend Yield | 0.33% | 0.28% | 0.80% | 0.72% | 0.54% | 0.53% |
Payout Ratio | 443.74% | 569.87% | 638.70% | 30.53% | 30.56% | 22.96% |
Buyback Yield / Dilution | 11.84% | 13.84% | 27.97% | -0.26% | 0.53% | 0.98% |
Total Shareholder Return | 12.18% | 14.13% | 28.76% | 0.46% | 1.07% | 1.50% |